| Product Name | Pioglitazone |
|---|---|
| CAS Number | 111025-46-8 |
| Molecular Formula | C19H20N2O3S |
| Molecular Weight | 356.44 |
| Appearance | White to off-white crystalline powder |
| Assay (HPLC) | ≥98% |
| Loss on Drying | ≤0.5% |
| Residue on Ignition | ≤0.1% |
| Heavy Metals | ≤10 ppm |
| Melting Point | 183-186°C |
| Specific Rotation | N/A (racemic) |
Need help? Contact our team

Synonyms
Pioglitazone is a thiazolidinedione that has been a cornerstone in type 2 diabetes management for over two decades. It works by targeting PPAR-γ, a nuclear receptor that directly influences insulin sensitivity in adipose tissue, muscle, and liver. Unlike many other antidiabetic drugs that merely stimulate insulin release, pioglitazone addresses the root issue—insulin resistance—helping patients achieve better long-term glycemic control.
For manufacturers, pioglitazone remains a reliable, cost-effective API with a well-established safety profile. We supply pioglitazone as a high-purity crystalline powder, every batch shipped with a full COA, and we offer flexible packaging from 1 kg trial orders to bulk container shipments. Our global logistics network ensures timely delivery to any destination.